Growth Metrics

Biocryst Pharmaceuticals (BCRX) Invested Capital: 2009-2014

Historic Invested Capital for Biocryst Pharmaceuticals (BCRX) over the last 6 years, with Dec 2014 value amounting to $75.6 million.

  • Biocryst Pharmaceuticals' Invested Capital fell 23.26% to $64.0 million in Q3 2015 from the same period last year, while for Sep 2015 it was $64.0 million, marking a year-over-year decrease of 23.26%. This contributed to the annual value of $75.6 million for FY2014, which is 6817.14% up from last year.
  • According to the latest figures from FY2014, Biocryst Pharmaceuticals' Invested Capital is $75.6 million, which was up 6,817.14% from -$1.1 million recorded in FY2013.
  • In the past 5 years, Biocryst Pharmaceuticals' Invested Capital ranged from a high of $75.6 million in FY2014 and a low of -$1.1 million during FY2013.
  • For the 3-year period, Biocryst Pharmaceuticals' Invested Capital averaged around $24.7 million, with its median value being -$454,000 (2012).
  • Its Invested Capital has fluctuated over the past 5 years, first plummeted by 148.02% in 2013, then soared by 6,817.14% in 2014.
  • Yearly analysis of 5 years shows Biocryst Pharmaceuticals' Invested Capital stood at $65.5 million in 2010, then plummeted by 77.40% to $14.8 million in 2011, then tumbled by 103.07% to -$454,000 in 2012, then crashed by 148.02% to -$1.1 million in 2013, then surged by 6,817.14% to $75.6 million in 2014.